• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹膜透析患者高血压发生过程中的盐和液体摄入

Salt and fluid intake in the development of hypertension in peritoneal dialysis patients.

作者信息

Chen Wei, Cheng Li-Tao, Wang Tao

机构信息

Institute of Nephrology, Third Hospital, Peking University, Beijing, China.

出版信息

Ren Fail. 2007;29(4):427-32. doi: 10.1080/08860220701260461.

DOI:10.1080/08860220701260461
PMID:17497464
Abstract

BACKGROUND

Although fluid overload contributes to hypertension in CAPD patients, less attention has been paid to the role of excess salt and fluid intake. Therefore, we investigated the role of salt and fluid intake in the development of hypertension in CAPD patients.

METHODS

A total of 165 stable CAPD patients were included into this study. Based on the blood pressure in three consecutive months, they were divided into three groups: persistent hypertensive (PH; n = 33), intercurrent hypertensive (IH; n = 58) and persistent normotensive (PN; n = 74). The IH group was further divided into two phases: normotensive and hypertensive. Fluid status was evaluated by clinical assessment and bioimpedance analysis (BIA).

RESULTS

There were no differences in age, gender, and duration of dialysis among groups. Patients were more fluid overloaded in the PH group. Extracellular water (ECW), total body water (TBW), and normalized extracellular water by height (NECW) were higher in the PH group than the PN group (16.77 +/- 3.62 L vs. 14.61 +/- 2.92 L for ECW, p < 0.01; 32.22 +/- 8.23 L vs. 28.98 +/- 6.00 L for TBW, p < 0.05; and 10.28 +/- 1.86 L/m vs. 9.08 +/- 1.63 L/m for NECW, p < 0.01). However, patients in the PH group also had more total fluid removal (TFR) and total sodium removal (TSR) compared with the PN group (1346.82 +/- 431.27 mL/d vs. 1139.28 +/- 412.65 mL/d for TFR, p < 0.05; and 141.52 +/- 61.57 mmol/d vs. 102.42 +/- 62.51 mmol/d for TSR, p < 0.01). The same trend was demonstrated when compared values of hypertensive and normotensive phase in IH group; patients had higher ECW, TBW, NECW, TSR, and PNa when they were in hypertensive phase than in the normotensive phase.

CONCLUSIONS

This study confirmed that fluid overload was closely associated with the development of hypertension in CAPD patients. It also showed that hypertensive patients were in general more fluid overloaded despite a higher fluid and sodium removal as compared with normotensive patients.

摘要

背景

尽管液体超负荷会导致持续性非卧床腹膜透析(CAPD)患者发生高血压,但人们对过量盐和液体摄入的作用关注较少。因此,我们研究了盐和液体摄入在CAPD患者高血压发生中的作用。

方法

本研究共纳入165例稳定的CAPD患者。根据连续三个月的血压情况,将他们分为三组:持续性高血压组(PH;n = 33)、间歇性高血压组(IH;n = 58)和持续性血压正常组(PN;n = 74)。IH组进一步分为两个阶段:血压正常阶段和高血压阶段。通过临床评估和生物电阻抗分析(BIA)评估液体状态。

结果

各组患者在年龄、性别和透析时间方面无差异。PH组患者的液体超负荷情况更严重。PH组的细胞外液(ECW)、总体液(TBW)和按身高标准化的细胞外液(NECW)均高于PN组(ECW:16.77±3.62 L对14.61±2.92 L,p < 0.01;TBW:32.22±8.23 L对28.98±6.00 L,p < 0.05;NECW:10.28±1.86 L/m对9.08±1.63 L/m,p < 0.01)。然而,与PN组相比,PH组患者的总液体清除量(TFR)和总钠清除量(TSR)也更高(TFR:1346.82±431.27 mL/d对1139.28±412.65 mL/d,p < 0.05;TSR:141.52±61.57 mmol/d对102.42±62.51 mmol/d,p < 0.01)。比较IH组高血压阶段和血压正常阶段的值时也显示出相同趋势;患者在高血压阶段的ECW、TBW、NECW、TSR和血钠水平高于血压正常阶段。

结论

本研究证实液体超负荷与CAPD患者高血压的发生密切相关。研究还表明,与血压正常的患者相比,高血压患者尽管液体和钠清除量较高,但总体液体超负荷情况更严重。

相似文献

1
Salt and fluid intake in the development of hypertension in peritoneal dialysis patients.腹膜透析患者高血压发生过程中的盐和液体摄入
Ren Fail. 2007;29(4):427-32. doi: 10.1080/08860220701260461.
2
Residual renal function and volume control in peritoneal dialysis patients.腹膜透析患者的残余肾功能与容量控制
Nephron Clin Pract. 2006;104(1):c47-54. doi: 10.1159/000093670. Epub 2006 May 1.
3
Salt intake and hypervolemia in the development of hypertension in peritoneal dialysis patients.腹膜透析患者高血压发生过程中的盐摄入与血容量过多
Adv Perit Dial. 2012;28:10-5.
4
Volume status and blood pressure in continuous ambulatory peritoneal dialysis patients.持续性非卧床腹膜透析患者的容量状态与血压
Blood Purif. 2005;23(5):373-8. doi: 10.1159/000087194. Epub 2005 May 27.
5
Cyclosporine enhances salt sensitivity of body water composition as assessed by impedance among psoriatic patients with normal renal function.通过阻抗评估,环孢素会增强肾功能正常的银屑病患者体内水分成分的盐敏感性。
J Ren Nutr. 2004 Oct;14(4):226-32.
6
Why is there significant overlap in volume status between hypertensive and normotensive patients on dialysis?为何透析的高血压患者和血压正常的患者在容量状态上存在显著重叠?
Am J Nephrol. 2008;28(3):508-16. doi: 10.1159/000113727. Epub 2008 Jan 18.
7
Relations between malnutrition-inflammation-atherosclerosis and volume status. The usefulness of bioimpedance analysis in peritoneal dialysis patients.营养不良-炎症-动脉粥样硬化与容量状态的关系。生物电阻抗分析在腹膜透析患者中的应用。
Nephrol Dial Transplant. 2011 May;26(5):1708-16. doi: 10.1093/ndt/gfq588. Epub 2010 Oct 4.
8
[Arterial hypertension in chronic kidney failure: a volume-dependent pathology or a disease due to malnutrition?].[慢性肾衰竭中的动脉高血压:容量依赖性病理状态还是营养不良所致疾病?]
G Ital Cardiol. 1999 Mar;29(3):284-90.
9
Enrollment fluid status is independently associated with long-term survival of peritoneal dialysis patients.入组时的液体状态与腹膜透析患者的长期生存独立相关。
Adv Perit Dial. 2008;24:79-83.
10
Reference values for multifrequency bioimpedance analysis in dialysis patients.透析患者多频生物电阻抗分析的参考值
Blood Purif. 2004;22(3):301-6. doi: 10.1159/000078761.

引用本文的文献

1
Risk prediction of cardiovascular events in peritoneal dialysis patients.腹膜透析患者心血管事件的风险预测
BMC Nephrol. 2025 Apr 5;26(1):177. doi: 10.1186/s12882-025-04091-6.
2
Very low-calorie ketogenic diet (VLCKD): an antihypertensive nutritional approach.极低卡路里生酮饮食(VLCKD):一种降压的营养方法。
J Transl Med. 2023 Feb 17;21(1):128. doi: 10.1186/s12967-023-03956-4.
3
Assessment of Hydration Status and Blood Pressure in a Tertiary Care Hospital at Al-Khobar.胡巴尔一家三级护理医院的水合状态与血压评估
Cureus. 2022 Aug 5;14(8):e27706. doi: 10.7759/cureus.27706. eCollection 2022 Aug.
4
Hypertension in patients on dialysis: diagnosis, mechanisms, and management.透析患者的高血压:诊断、机制与管理
J Bras Nefrol. 2019 Jul-Sep;41(3):400-411. doi: 10.1590/2175-8239-jbn-2018-0155. Epub 2018 Nov 8.
5
The effect of dietary salt on blood pressure in individuals receiving chronic dialysis: a systematic review and meta-analysis of randomised controlled trials.膳食盐对接受慢性透析个体血压的影响:一项随机对照试验的系统评价和荟萃分析。
J Hum Hypertens. 2019 Apr;33(4):319-326. doi: 10.1038/s41371-018-0131-5. Epub 2018 Nov 9.
6
Sodium removal by peritoneal dialysis: a systematic review and meta-analysis.腹膜透析清除钠的效果:系统评价和荟萃分析。
J Nephrol. 2019 Apr;32(2):231-239. doi: 10.1007/s40620-018-0507-1. Epub 2018 Jul 5.
7
Serum Endocan as a Predictive Marker for Decreased Urine Volume in Peritoneal Dialysis Patients.血清内配蛋白作为腹膜透析患者尿量减少的预测标志物。
Med Sci Monit. 2017 Mar 26;23:1464-1470. doi: 10.12659/msm.900693.
8
Prevalence and risk factors of fluid overload in Southern Chinese continuous ambulatory peritoneal dialysis patients.中国南方地区持续性非卧床腹膜透析患者液体超负荷的患病率及危险因素。
PLoS One. 2013;8(1):e53294. doi: 10.1371/journal.pone.0053294. Epub 2013 Jan 14.
9
Dietary sodium in chronic kidney disease: a comprehensive approach.慢性肾脏病中的膳食钠:一种综合方法。
Semin Dial. 2010 Jul-Aug;23(4):415-21. doi: 10.1111/j.1525-139X.2010.00752.x. Epub 2010 Jun 14.